ECM
LLY icon

Endurant Capital Management’s Eli Lilly LLY Stock Holding History

Endurant Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-38,311
Closed -$12.4M – 62
2022
Q3 		$12.4M Buy
+38,311
New +$12.1M 4.03% 7
2017
Q3 		– Sell
-9,600
Closed -$790K – 97
2017
Q2 		$790K Sell
9,600
-8,100
-46% -$661K 0.22% 74
2017
Q1 		$1.49M Sell
17,700
-20,400
-54% -$1.63M 0.48% 56
2016
Q4 		$2.8M Buy
+38,100
New +$2.84M 1.16% 33

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Endurant Capital Management's LLY Position: Q4 2022 in Review

Endurant Capital Management sold out of Eli Lilly (LLY) in Q4 2022, closing a stake of 38,311 shares — an estimated $12.4M sold.

Endurant Capital Management first reported a position in LLY in Q4 2016 and held it in 4 quarters. The position peaked at $12.4M in Q3 2022. 2,672 funds tracked by Wall St. Rank hold LLY as of Q4 2022.

  • Endurant Capital Management reported no remaining Eli Lilly position as of Q4 2022 after selling out during the quarter.
  • Endurant Capital Management sold 38,311 Eli Lilly shares in Q4 2022, an estimated $12.4M.
  • Endurant Capital Management first reported a position in Eli Lilly in Q4 2016 and held it in 4 quarters.
  • Endurant Capital Management's Eli Lilly position peaked at $12.4M in Q3 2022.
  • 2,672 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.

Based on Endurant Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.